FORM 8-K

Company

Theriva Biologics, Inc.

Filed

July 18, 2012

Period of Report

July 18, 2012

Accession Number

0001144204-12-040043

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →